Key result
Infective endocarditis (vs non-endocarditis) in patients undergoing mitral annular reconstruction showed no significant difference in overall survival (mortality 26.5% vs 17.2%; P=0.565).
Why the study?
What are the early and long-term outcomes of mitral annular reconstruction with pericardium during mitral valve replacement in patients with and without endocarditis?
Cohort (n=78)
What are the early and long-term outcomes of mitral annular reconstruction with pericardium during mitral valve replacement in patients with and without endocarditis?
Absolute Event Rate: 26.5% vs 17.2%
p-value: p=0.565
Mitral annular reconstruction with pericardium during mitral valve replacement provides acceptable early and long-term outcomes for both endocarditis and non-endocarditis patients, though pre-operative LV dysfunction increases mortality risk.
No takes yet. Share an insight, caveat, or question.
May support pericardial mitral annular reconstruction in endocarditis; leaves open need for randomized confirmation of comparative outcomes.
Kim et al. (2018) conducted a cohort in Mitral valve disease requiring mitral annular reconstruction (n=78). Infective endocarditis vs. Non-endocarditis was evaluated on Overall mortality (p=0.565). Infective endocarditis (vs non-endocarditis) in patients undergoing mitral annular reconstruction showed no significant difference in overall survival (mortality 26.5% vs 17.2%; P=0.565).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: